Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Galli

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Blood|October 24, 2002
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literatureMonica Galli, Davide Luciani, Guido Bertolini, et al.
Haematologica|September 21, 2004
Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myelomaMonica Galli, Francesca Elice, Claudia Crippa, et al.
Annals of Hematology|July 28, 2009
A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myelomaMonica Galli, Silvia Salmoiraghi, Joseé Golay, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|August 7, 2004
Antiphospholipid antibodies in lymphoma: prevalence and clinical significanceSimona Pusterla, Sara Previtali, Stefana Marziali, et al.
Biochemistry|November 27, 2002
Kinetics of prothrombin-mediated binding of lupus anticoagulant antibodies to phosphatidylserine-containing phospholipid membranes: an ellipsometric studyGeorge M Willems, Marie P Janssen, Paul Comfurius, et al.
British Journal of Haematology|November 14, 2023
Genetic defects of gamma-secretase genes in a multiple myeloma patient with high and dysregulated BCMA surface density: A case reportIrene Cattaneo, Rut Valgardsdottir, Roberta Cavagna, et al.
Blood|November 25, 2003
Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patientsMassimo Cugno, Mara Cabibbe, Monica Galli, et al.
Haematologica|January 12, 2005
Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 casesNicola Vianelli, Monica Galli, Antonio de Vivo, et al.
Haematologica|December 7, 2005
Feasibility and outcome of tandem stem cell autotransplants in multiple myelomaMonica Galli, Antonio Nicolucci, Miriam Valentini, et al.
Blood|April 19, 2007
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) studyMonica Galli, Giovanna Borrelli, Eva Marie Jacobsen, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Blood|October 24, 2002
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literatureMonica Galli, Davide Luciani, Guido Bertolini, et al.
Haematologica|September 21, 2004
Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myelomaMonica Galli, Francesca Elice, Claudia Crippa, et al.
Annals of Hematology|July 28, 2009
A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myelomaMonica Galli, Silvia Salmoiraghi, Joseé Golay, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|August 7, 2004
Antiphospholipid antibodies in lymphoma: prevalence and clinical significanceSimona Pusterla, Sara Previtali, Stefana Marziali, et al.
Biochemistry|November 27, 2002
Kinetics of prothrombin-mediated binding of lupus anticoagulant antibodies to phosphatidylserine-containing phospholipid membranes: an ellipsometric studyGeorge M Willems, Marie P Janssen, Paul Comfurius, et al.
British Journal of Haematology|November 14, 2023
Genetic defects of gamma-secretase genes in a multiple myeloma patient with high and dysregulated BCMA surface density: A case reportIrene Cattaneo, Rut Valgardsdottir, Roberta Cavagna, et al.
Blood|November 25, 2003
Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patientsMassimo Cugno, Mara Cabibbe, Monica Galli, et al.
Haematologica|January 12, 2005
Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 casesNicola Vianelli, Monica Galli, Antonio de Vivo, et al.
Haematologica|December 7, 2005
Feasibility and outcome of tandem stem cell autotransplants in multiple myelomaMonica Galli, Antonio Nicolucci, Miriam Valentini, et al.
Blood|April 19, 2007
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) studyMonica Galli, Giovanna Borrelli, Eva Marie Jacobsen, et al.
Pageof 6